For up-to-date safety information, eligibility criteria, and program guidelines, visit the official Brello Health website
When will Retatrutide be officially approved
However, the drug does not have Food And Drug Administration (FDA) approval for this purpose
Seek immediate medical attention (call 999 or attend A&E) if you develop : Signs of severe dehydration: dizziness, confusion, reduced urine output despite drinking fluids, rapid heartbeat Symptoms of diabetic ketoacidosis: excessive thirst, frequent urination, nausea, vomiting, abdominal pain, fruity-smelling breath, confusion (Note: GLP-1 medications do not cause DKA, but it can occur in type 1 diabetes or ketosis-prone type 2 diabetes, especially during illness) Severe flank pain with fever: may indicate pyelonephritis (kidney infection) If you experience persistent vomiting or diarrhoea from GLP-1 therapy and cannot maintain adequate fluid intake, seek urgent medical advice as there is a risk of dehydration and acute kidney injury